featured
Personalized Extended Interval Dosing of Natalizumab in MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Personalized Extended Interval Dosing of Natalizumab in MS: A Prospective Multicenter Trial
Neurology 2020 Aug 11;95(6)e745-e754, ZLE van Kempen, ELJ Hoogervorst, MP Wattjes, NF Kalkers, JP Mostert, BI Lissenberg-Witte, A de Vries, A Ten Brinke, BW van Oosten, F Barkhof, CE Teunissen, BMJ Uitdehaag, T Rispens, J KillesteinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.